Join the Prurigo Nodularis group to help and get support from people like you.
Prurigo Nodularis News
Nemolizumab Improves Symptoms in Prurigo Nodularis
THURSDAY, Oct. 26, 2023 – For patients with moderate-to-severe prurigo nodularis, nemolizumab improves symptoms, according to a study published in the Oct. 26 issue of the New England Journal of...
Dupixent (dupilumab) Approved by FDA as the First and Only Treatment Indicated for Prurigo Nodularis
Dupixent significantly reduced itch and skin lesions compared to placebo in direct-to-Phase 3 program consisting of two pivotal trials About 75,000 adults in the U.S. living with prurigo nodularis...
Ask a question
To post your own question to this support group, sign in or create an account.